urinary bladder neoplasms

New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors
Aristotelis Bamias, Axel Merseburger, Yohann Loriot, Nicholas James, Ernest Choy, Daniel Castellano, F Lopez-Rios, Fabio Calabrò, Mario Kramer, Guillermo de Velasco, Roubini Zakopoulou, Kimon Tzannis, Cora N Sternberg

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e005977; DOI: 10.1136/jitc-2022-005977
Impact of immune-related adverse events on the therapeutic efficacy of pembrolizumab in urothelial carcinoma: a multicenter retrospective study using time-dependent analysis
Taketo Kawai, Satoru Taguchi, Tohru Nakagawa, Jun Kamei, Yu Nakamura, Daisuke Obinata, Kenya Yamaguchi, Tomoyuki Kaneko, Shigenori Kakutani, Mayuko Tokunaga, Yukari Uemura, Yusuke Sato, Yutaka Enomoto, Hiroaki Nishimatsu, Tetsuya Fujimura, Hiroshi Fukuhara, Satoru Takahashi, Haruki Kume

Journal for ImmunoTherapy of Cancer Feb 2022, 10 (2) e003965; DOI: 10.1136/jitc-2021-003965
Unique characteristics of tertiary lymphoid structures in kidney clear cell carcinoma: prognostic outcome and comparison with bladder cancer
Tsukasa Masuda, Nobuyuki Tanaka, Kimiharu Takamatsu, Kyohei Hakozaki, Ryohei Takahashi, Tadatsugu Anno, Ryohei Kufukihara, Kazunori Shojo, Shuji Mikami, Toshiaki Shinojima, Kazuhiro Kakimi, Tatsuhiko Tsunoda, Eriko Aimono, Hiroshi Nishihara, Ryuichi Mizuno, Mototsugu Oya

Journal for ImmunoTherapy of Cancer Mar 2022, 10 (3) e003883; DOI: 10.1136/jitc-2021-003883
Immunosuppressive tumor-associated macrophages expressing interlukin-10 conferred poor prognosis and therapeutic vulnerability in patients with muscle-invasive bladder cancer
Yijia Xu, Han Zeng, Kaifeng Jin, Zhaopei Liu, Yu Zhu, Le Xu, Zewei Wang, Yuan Chang, Jiejie Xu

Journal for ImmunoTherapy of Cancer Mar 2022, 10 (3) e003416; DOI: 10.1136/jitc-2021-003416
FimH confers mannose-targeting ability to Bacillus Calmette-Guerin for improved immunotherapy in bladder cancer
Yang Zhang, Fan Huo, Qiang Cao, Ru Jia, Qiju Huang, Zhu A Wang, Dan Theodorescu, Qiang Lv, Pengchao Li, Chao Yan

Journal for ImmunoTherapy of Cancer Mar 2022, 10 (3) e003939; DOI: 10.1136/jitc-2021-003939
Novel intravesical bacterial immunotherapy induces rejection of BCG-unresponsive established bladder tumors
Eduardo Moreo, Santiago Uranga, Ana Picó, Ana Belén Gómez, Denise Nardelli-Haefliger, Carlos del Fresno, Ingrid Murillo, Eugenia Puentes, Esteban Rodríguez, Mar Vales-Gómez, Julian Pardo, David Sancho, Carlos Martín, Nacho Aguilo

Journal for ImmunoTherapy of Cancer Jul 2022, 10 (7) e004325; DOI: 10.1136/jitc-2021-004325
Efficacy of pembrolizumab and comprehensive CD274/PD-L1 profiles in patients previously treated with chemoradiation therapy as radical treatment in bladder cancer
Kazuki Nishimura, Kyosuke Nishio, Kensuke Hirosuna, Kazumasa Komura, Takuo Hayashi, Wataru Fukuokaya, Ayako Ura, Taizo Uchimoto, Ko Nakamura, Tatsuo Fukushima, Yusuke Yano, Nobushige Takahashi, Keita Nakamori, Shoko Kinoshita, Tomohisa Matsunaga, Takeshi Tsutsumi, Takuya Tsujino, Kohei Taniguchi, Tomohito Tanaka, Hirofumi Uehara, Kiyoshi Takahara, Teruo Inamoto, Yoshinobu Hirose, Takahiro Kimura, Shin Egawa, Haruhito Azuma

Journal for ImmunoTherapy of Cancer Jan 2022, 10 (1) e003868; DOI: 10.1136/jitc-2021-003868
Concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with localized urothelial cancer of bladder: results from phase II study, BTCRC-GU15-023
Monika Joshi, Leonard Tuanquin, Junjia Zhu, Vonn Walter, Todd Schell, Matthew Kaag, Deepak Kilari, Jiangang Liao, Sheldon L Holder, Hamid Emamekhoo, Alexander Sankin, Suzzane Merrill, Hong Zheng, Joshua Warrick, Ralph Hauke, Benjamin Gartrel, Mark Stein, Joseph Drabick, David J Degraff, Yousef Zakharia

Journal for ImmunoTherapy of Cancer Feb 2023, 11 (2) e006551; DOI: 10.1136/jitc-2022-006551
Indication-specific tumor evolution and its impact on neoantigen targeting and biomarkers for individualized cancer immunotherapies
Amy A Lo, Andrew Wallace, Daniel Oreper, Nicolas Lounsbury, Charles Havnar, Ximo Pechuan-Jorge, Thomas D Wu, Richard Bourgon, Ryan Jones, Katrina Krogh, Guang-Yu Yang, Oliver A Zill

Journal for ImmunoTherapy of Cancer Oct 2021, 9 (10) e003001; DOI: 10.1136/jitc-2021-003001
Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer
Shaoming Zhu, A-Hong Ma, Zheng Zhu, Elio Adib, Ting Rao, Na Li, Kaiyuan Ni, Veera Chandra Sekhar Reddy Chittepu, Rao Prabhala, Juan Garisto Risco, David Kwiatkowski, Kent Mouw, Guru Sonpavde, Fan Cheng, Chong-xian Pan

Journal for ImmunoTherapy of Cancer Nov 2021, 9 (11) e002917; DOI: 10.1136/jitc-2021-002917

Main menu

urinary bladder neoplasms

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

urinary bladder neoplasms

Pages